Dermapharm Holding SE sell ReynadJ
Start price
05.08.24
/
0%
€34.60
Target price
05.08.25
-
Performance (%)
-6.79%
Price
10.09.24
€32.25
Summary
This prediction is currently active. With a performance of -6.79%, the SELL prediction for Dermapharm Holding SE by ReynadJ is down slightly. This prediction currently runs until 05.08.25. The prediction end date can be changed by ReynadJ at any time. This prediction was marked as speculative and is excluded from ReynadJ's performance statistics.Dermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Dermapharm Holding SE | -4.586% | -4.586% |
| iShares Core DAX® | -1.611% | 3.135% |
| iShares Nasdaq 100 | -0.500% | 0.775% |
| iShares Nikkei 225® | -1.483% | 4.610% |
| iShares S&P 500 | -0.501% | 1.914% |
According to ReynadJ what are the pros and cons of Dermapharm Holding SE for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
Comments by ReynadJ for this prediction
In the thread Dermapharm Holding SE diskutieren
Sell Dermapharm Holding SE